ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2 Press release … to what we have observed with early but promising data for sepofarsen in patients with LCA10,” said Daniel A. de Boer, … March 11, 2019
ProQR traite le premier patient dans l’essai STELLAR de Phase 1/2 du QR-421a pour le syndrome d’Usher de type 2 Press release … avec des données précoces mais prometteuses concernant Sepofarsen chez les patients atteints de LCA10 », a déclaré … March 11, 2019
ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update Press release … and scheduled trials, including the pivotal trial of sepofarsen for Leber congenital amaurosis 10. ProQR is … March 31, 2020